Stanford Regenerates Knee Cartilage, Paving Way for Arthritis Treatment
TL;DR Summary
Stanford researchers block the aging-related gerozyme 15-PGDH with an injectable (and now an oral drug in trials), triggering cartilage regeneration in mouse knee joints and human tissue samples, reversing age-related cartilage loss and showing promise for preventing arthritis after knee injuries.
- Scientists at Stanford Find a Way To Regrow Aging Knee Cartilage and Prevent Arthritis My Modern Met
- 32 million Americans affected: this injection regrows cartilage in just months Futura, le média qui explore le monde
- Breakthrough drug target may help regrow cartilage, ease osteoarthritis pain theweek.in
- Stanford University has identified a protein linked to ageing, 15-PGDH, which appears to hinder cartilage repair; by inhibiting it, ‘worn-out’ knees regain their thickness and function, marking a preliminary but significant step in the fight against osteoarthritis OkDiario
Reading Insights
Total Reads
0
Unique Readers
4
Time Saved
27 min
vs 27 min read
Condensed
99%
5,393 → 41 words
Want the full story? Read the original article
Read on My Modern Met